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Cleft palate is among the most common birth defects in humans, caused by a failure in the complex multistep developmental process of
palatogenesis. It has been recently shown that transforming growth factor h3 (Tgf-h3) is an absolute requirement for successful palatal
fusion, both in mice and humans. However, very little is known about the mechanisms of Tgf-h3 signaling during this process. Here we show
that putative Tgf-h type I receptors, Alk-1, Alk-2, and Alk-5, are all endogenously expressed in the palatal epithelium. Activation of Alk-5 in
the Tgf-h3 ( / ) palatal epithelium is able to rescue palatal fusion, whereas inactivation of Alk-5 in the wild-type palatal epithelium
prevents palatal fusion. The effect of Alk-2 is similar, but less pronounced. The induction of fusion by activation of Alk-5 or Alk-2 is stronger
in the posterior parts of the palates at the embryonic day 14 (E14), while their activation at E13.5 also restores anterior fusion, reflecting the
natural anterior–posterior direction of palate maturation in vivo. We also show that Smad2 is endogenously activated in the palatal midline
epithelial seam (MES) during the fusion process. By using a mutant Alk-5 receptor that is an active kinase but is unable to activate Smads, we
show that activation of Smad-independent Tgf-h responses is not sufficient to induce fusion of shelves deficient in Tgf-h3. Based on these
observations, we conclude that the Smad2-dependent Alk-5 signaling pathway is dominant in palatal fusion driven by Tgf-h3.
D 2003 Elsevier Inc. All rights reserved.Keywords: Cleft palate; Palate fusion; Tgf-h3 knockout mouse; Tgf-h receptor; Alk-5; Smad2; Smad7; Recombinant adenovirusIntroduction
Formation of the secondary palate (palatogenesis) is a
multistep process required to separate the oral cavity from
the nasal cavity and nasopharynx. Failure of palatogenesis
results in cleft palate, one of the most common birth
defects in humans (Ferguson, 1988). One of the key
components in palatal fusion is transforming growth factor
h3 (Tgf-h3). In mice, this is strongly expressed in tips of
prefusion palatal shelves, called the medial edge epithelium
(MEE) (Fitzpatrick et al., 1990; Pelton et al., 1990). In
addition, bi-allelic inactivation of the Tgf-h3 gene has been
shown to result in cleft palate (Kaartinen et al., 1995;
Proetzel et al., 1995).0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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E-mail address: vkaartinen@chla.usc.edu (V. Kaartinen).Murine palatogenesis takes place between embryonic
days 12 and 15 (E12–E15) (Ferguson, 1988). Palatal
shelves grow out bilaterally from maxillary prominences.
Around E14, they rapidly elevate to a horizontal position,
become adherent in the midline, before apposing palatal
shelves finally fuse. During the initial stage of the fusion
process, MEE cells form a midline epithelial seam (MES)
separating mesenchymes of the two apposing shelves.
Subsequently, the MES is rapidly degraded, allowing for
mesenchymal continuity (confluence). In Tgf-h3 knockouts,
palatal shelves grow normally, exhibit normal and symmet-
ric elevation, and even come into close contact in the
midline at E14. Despite this, fusion fails to occur. Interest-
ingly, Tgf-h3 ( / ) palatal shelves also display impaired
induction of mesenchymal confluence when placed in tight
contact in organ cultures. Thus, confirming that the primary
defect is caused by epithelial malfunction (Kaartinen et al.,
1995; Kaartinen et al., 1997; Lidral et al., 1998; Martinez-
Alvarez et al., 2000; Proetzel et al., 1995; Taya et al., 1999).
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biological responses through a receptor signaling complex,
which is a heterotetramer consisting of two type II and two
type I receptors (Derynck and Feng, 1997; Massague, 1998;
Massague, 2000; Massague and Chen, 2000). Type II
receptors (ThR-II), which are constitutively active serine–
threonine kinases, are brought into a complex with type I
receptors by a dimeric ligand. Subsequently, type II recep-
tors phosphorylate the GS region in type I receptors,
resulting in their activation. Type I receptors (Alks) then
phosphorylate and activate cytoplasmic receptor-regulated
Smad proteins (R-Smads) on their carboxy-terminal Ser
residues. The downstream signaling specificity of the type
I receptor is defined by the L45 loop between the kinase
subdomains IV and V (Feng and Derynck, 1997). Upon
phosphorylation, R-Smads are released from the scaffolding
protein called Sara (Smad anchor for receptor activation) to
form an oligomeric complex with Smad4 (co-Smad). This
complex in turn is imported into the cell nucleus, where it is
involved in transcriptional regulations. The inhibitory
Smads (I-Smads, e.g., Smad6 and Smad7) function as
negative regulators of the Tgf-h signaling pathway.
Although Tgf-hs predominantly signal via Alk-5 (Piek et
al., 1999b), the involvement of other Alks in the Tgf-h-
induced cell differentiation cannot be excluded (Lai et al.,
2000; Miettinen et al., 1994). Interestingly, Alk-1, closely
related to Alk-2, mediates Tgf-h signaling specifically in
endothelial cells (Goumans et al., 2002). Unfortunately,
Alk-1, Alk-2, and Alk-5 knockout mice all die at E6–E8
for different reasons (Gu et al., 1999; Larsson et al., 2001;
Mishina et al., 1999; Oh et al., 2000), preventing their
utilization in palatal studies.
The aim of this study was to identify the downstream
signaling pathways involved in Tgf-h3 signal transduction
during palatogenesis. We studied the endogenous expression
of all known and putative Tgf-h type I receptors, activation
of Smads in prefusion and fusing palatal shelves, as well as
their role in the process of midline epithelial seam disap-
pearance. We identify Alk-5 as the primary Tgf-h3 type I
receptor in palatal fusion and demonstrate that Smads are
involved in the midline seam disappearance. Moreover, our
results imply that the canonical Alk-5/Smad pathway is
complemented by other signaling mechanisms, potentially
involving bone morphogenetic protein (Bmp)-Smads and
Mapks.Materials and methods
Mouse breeding and embryo collection
Tgf-h3 knockout mice were generated in our laboratory
(Kaartinen et al., 1995). For this study, Tgf-h3 (+/) females
were crossed with (+/) males (C57BL/6 background)
during the dark period of controlled light cycle. The presence
of vaginal plugs was designated as day 0 hour 0. Femaleswere euthanized by CO2 according to institutional and
national guidelines, and E14 embryos were collected in
Hanks’ balanced salt solution on ice.
Organ culture of palatal shelves
Palatal shelves were dissected from fetuses using micro-
scissors, placed on Millipore filter discs, and cultured for 50
h in BGJb medium (Gibco) supplemented with vitamin C
(Kaartinen et al., 1997; Sun et al., 1998). Tissues were fixed
in freshly prepared 4% paraformaldehyde in PBS.
Generation of adenoviral vectors
Recombinant adenovirus expressing FLAG-tagged con-
stitutively active L45 loop-mutated Alk-5 (Yu et al., 2002)
was generated by subcloning the EcoRI–HindIII fragment
from the Alk-5TDmL45 expression vector (generous gift
from Dr. Ying E. Zhang, NIH) into the Gateway ENTR 2B
vector (Invitrogen). Subsequently, recombinant adenovi-
ruses were produced by using the Gateway pAd/cmv/v5-
DEST vector and Virapower adenoviral expression system
according to manufacturer’s instructions. Generation of
other dominant-negative and constitutively active Alk
viruses and Smad viruses has been previously described
(Nakao et al., 1997; Piek et al., 1999a). Viral stocks were
amplified in replication-competent 293A cells. Desired
protein production was verified by GFP detection, or by
immunoblot analysis of the HA- or FLAG-tagged proteins.
Viruses were harvested by freezing–thawing the cell sus-
pension, purified using the Virakit Adeno (Virapur) kit, and
concentrated in Millipore Centriprep YM-50 columns. Ti-
tration was carried out as described in the application
manual and scored according to the Karber’s statistical
method. Final viral concentrations were around 1010 plaque
forming units per milliliter (pfu/ml).
Evaluation of adenoviral vectors
NMuMG cells were used to test expression efficiency
and biological effects of adenoviral vectors. Viral stocks
were added to a culture medium (DMEM, 10% FBS,
penicillin–streptomycin, and insulin 10 Ag/ml) to reach
final concentrations 108, 107, 106, or 105 pfu/ml, according
to given experimental settings. All viral preparations
efficiently induced high levels of recombinant protein
production, while only caAlk-5 (Alk-5TD) and caAlk-7
(Alk-7TD) viruses induced epithelial-to-mesenchymal
transdifferentiation and Smad2 phosphorylation. In concor-
dance with previous reports (Inman et al., 2002), the
effects of caAlk-5 and caAlk-7 both on EMT and on
Smad2 phosphorylation were efficiently inhibited by
SB431542. Moreover, Tgf-h3-induced Smad2 phosphory-
lation could be blocked by dnAlk-5 (Alk-5KR) as shown
before (Piek et al., 1999b), and also by dnAlk-7 (Alk-
7KR; not shown).
entalAdenoviral vectors in organ culture
Expression efficiency of the vectors was subsequently
tested in palatal tissues by transduction of explants, using
various titers of recombinant adenoviruses expressing
green fluorescent protein (GFP). After 24-h culture, mid-
line regions of explants transduced with the viral concen-
tration of 1  109 pfu/ml and above contained a large
amount of GFP-positive cells (Fig. 1a). Vectors for HA
epitope-tagged mutant Alk receptors were tested under
similar conditions. Anti-HA immunostaining in paraffin
sections demonstrated that most midline cells with the
epithelial phenotype expressed the recombinant protein
(Figs. 1b and c).
During experiments, dissected palatal shelves were
cultured for 1 h in 50-Al aliquots of medium containing
109 pfu/ml of viruses. Standard cultures were set up by
placing palatal shelves dissected from E14 fetuses into
close contact immediately after transduction. As an alter-
native approach, we induced protein expression 12 h be-
fore initiation of standard organ cultures. In order to
achieve this, we dissected palatal shelves at E13.5, kept
them apart in a shaking culture after the 1-h infection,
and then placed in contact at the time corresponding to
E14.
Scoring of palatal confluence and data analysis
Explants were serially sectioned maintaining the ante-
rior–posterior direction. An average of 80–100 sections
regularly distributed throughout the specimen were
scored for the mesenchymal confluence calculated as
described by Sun et al. (1998), that is, totally confluent
shelves had a relative fusion ratio 1.00 (100% fusion).
Experimental groups were statistically analyzed using
Wilcoxon’s rank sum test. Line graphs were generated
using Microsoft Excel software; X coordinate represents
the position of a given section in the specimen (the first
anterior section corresponds to the beginning of the X
axis), and Y coordinate shows the fusion percentage. To
simplify the data representation, individual curves were
averaged to obtain a single line, representing a general-
ized tendency of palatal shelves to reach mesenchymal
confluence in a given anteroposterior position for given
experiment.
Chemical inhibitors
The Alk-5 inhibitor, SB431542 (Callahan et al., 2002;
Inman et al., 2002), and the p38 Mapk inhibitor, SB203580
(Sigma), were dissolved in sterile DMSO to obtain 10 mM
stock solutions; 50 Al aliquots were stored at  80jC.
SB431542 stock was added to the appropriate medium in
a ratio 1:1000 to reach the final concentration 10 AM.
SB203580 was added in a ratio 1:100 to obtain the final
concentration 100 AM.
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For immunohistochemistry, palatal tissues were fixed
with 4% paraformaldehyde, embedded in 2% agarose, vibra-
tome-sectioned, and stained as floating sections, either with
phospho-Smad2 antibody (Kurisaki et al., 2003), phospho-
Smad1/5/8 antibody (Cell Signaling), or with anti-HA (USC
core facility) according to standard procedures (Harlow and
Lane, 1988). HRP- and Cy3-labeled secondary antibodies
were from Jackson ImmunoResearch Laboratories.
Western blot assays were performed according to stan-
dard procedures. Anti-phospho-Smad2 antibody was gener-
ated and purified as described (Kurisaki et al., 2003), anti-
Alk-5 antibody (sc-398) was from Santa Cruz, anti-HA from
USC core facility, and anti-FLAG was from Sigma. The
results were quantitatively analyzed using the Un-Scan-It
software (Silk Scientific).
Apoptosis and cell proliferation
For cell proliferation assays, palatal shelves were cul-
tured in the presence of 100 AM BrdU for 3 h before the
cultures were terminated in different time points. Zymed
BrdU Staining Kit (streptavidin–biotin) was used for de-
tection. Apoptotic cells were detected using the DeadEnd
Fluorometric TUNEL system (Promega).
RT-PCR
Dissected palatal shelves were immediately frozen in
liquid N2, disrupted in RLT buffer (Qiagen), and total
RNAs were isolated using Qiagen RNeasy kit. Qiagen
Omniscript RT and random hexamers were used for RT
reaction. Two microliters of the RT product, HotStarTaq
DNA polymerase (Qiagen), and the following primers were
used for PCR (h-actin as a quality control): Alk-1 sense 5V-
cttggggagcttcagaagggg-3V, antisense 5V-ggtggcctccagcatca-
gaga-3V; Alk-2 sense 5V-ctggaccagaggaacaaagg-3V, antisense
5V-ggcggggtcttacacgtca-3V; Alk-5, sense 5V-gccataaccg-
cactgtc-3V, antisense 5V-atgggcaatagctggtttt-3V; Alk-7 sense
5V-ctctgtcatgctaaccaacgg-3V, antisense 5V-tgcgatggacaggagg-
caaac-3V; h-actin sense 5V-gtgggccgctctaggcaccaa-3V, anti-
sense 5V-cggttggccttagggttcaggg-3V.
RNA in situ hybridization
Paraffin sections of embryonic heads were hybridized as
described (Moorman et al., 2001). The diversified 5VRNA
antisense fragments (see below) were used as digoxigenin-
labeled probes. For each probe, a sense probe was also
generated as a negative control. Alk probes were generated
by PCR and subcloned into the pSK Bluescript vector—Alk-
1: 310 bp (nts 6–316); Alk-2: 493 bp (nts1–497); Alk-5: 550
bp (nts 10–560); Alk-7: 241 bp (nts 142–383). Their identity
and orientation was verified by dideoxy-sequencing. Tgf-h3
probe has been described earlier (Blavier et al., 2001).
Biology 266 (2004) 96–108
Fig. 2. Smads are phosphorylated in the MES. Representative vibratome sections of the MES of E14 wild-type and Tgf-h3 ( / ) fetuses stained for phospho-
Smad2 (a– f), and phospho-Smad1/5/8 (g– l). Wild-type sections stained for phospho-Smad2 show a strong punctuated signal in the disappearing midline
epithelium as well as in oral and nasal triangles, while no similar pattern can be seen in the Tgf-h3 ( / ) samples. Scattered staining is also present in the
mesenchyme of wild-type and Tgf-h3 knockout sections, suggesting that this signal is not Tgf-h3-dependent. Some areas of bright red color in mesenchymal
compartments correspond to the autofluorescence of blood vessels with erythrocytes (visible in all color channels). Sections stained for phospho-Smad1/5/8
demonstrate a punctuated staining pattern both in wild-type and in Tgf-h3 ( / ) samples. (m) Detailed analysis (600 ) of the wild-type epithelial seam
stained for phospho-Smad2 demonstrates the nuclear localization of phosphorylated Smad2. (n) Prefusion wild-type palatal shelves show no Smad2 activation
(600 ).
Fig. 1. Adenoviral expression efficiency and detection of recombinant proteins in palatal organ cultures. (a) A pair of cultured shelves treated with 109 pfu/ml
of adenoviruses expressing GFP (magnification 25). After 12 h, green fluorescence can be observed in midline epithelium (white arrow). (b) To demonstrate
efficient adenoviral transduction in palatal explants, a section of wild-type palatal shelves expressing the dnAlk-5 construct is shown (brown signal, anti-HA
staining, magnification 200). (c) A high magnification view (400) of the boxed region in (b), showing the plasma membrane localization of the anti-HA
immunostaining, consistent with the expected protein localization (transmembrane receptor).
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Fig. 3. Smads are involved in palatogenesis. (a) Anterior-to-posterior overview of the fusion efficiency of Tgf-h3 ( / ) palatal explants (KO) overexpressing
Smad2 (averaged curve, n = 4, red), and of wild-type (wt) palatal shelves overexpressing Smad7 (n = 4, blue). Smad2 caused focal confluence up to 100% in
different points of the A–P axis of individual explants (one typical example, dotted orange line). Significant inhibitory effect on MES disappearance was
observed in explants overexpressing Smad7. (b) In addition to focal 100% confluence points, palatal explants overexpressing Smad2 often display a remarkably
thin midline epithelial seam (hematoxylin-eosin, magnification 200). (c–d) The Alk-5 inhibitor SB431542 prevents the mesenchymal confluence of the
anterior palate in vitro. Wild-type palatal explants cultured with the inhibitor have an apparent groove between the non-confluent anterior regions of palatal
shelves, which corresponds to a persistent MES (stereoscopic image, 15 ). The sudden end of the groove (green arrow) and the beginning of the fully
confluent posterior part corresponds to the middle section, showing a partial fusion (hematoxylin-eosin, 200 ). A control Tgf-h3 ( / ) explant has an
obvious groove between shelves along the entire midline (red arrows). (e) The anterior-to-posterior overview of the fusion efficiency of wild-type palatal
shelves treated with SB431542 (n = 6, red line), untreated wild-type palatal shelves (green line), and untreated Tgf-h3 ( / ) palatal shelves (blue line).
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Tgf-b3 signal during palatogenesis is mediated via the Alk/
Smad pathway
As an initial step, we studied the endogenous activation
of Smads, the downstream signaling molecules of Tgf-h
family receptors, during palatal fusion. Both Smad2 and
Bmp-Smads 1/5/8 were found to be activated in the MES.
Bmp-Smads were activated more ubiquitously in the entire
palatal epithelium, as well as in the mesenchyme, with no
difference between Tgf-h3 knockout and wild-type embryos
(Figs. 2g–l). Phospho-Smad2 staining was more specifical-
ly restricted to the wild-type MES, along the entire anteri-
or–posterior axis. It was not detected in either the MES ofFig. 4. Expression of endogenous Alk-1, Alk-2, Alk-5, and Alk-7 receptors in mous
palatal shelves at E14 (P). Brain RNAwas used as a positive control (+). Alk-1 (A
Alk-7 (D) is undetectable. (a– t) RNA in situ hybridization analysis of Alk mRNAs
shelves) and two locations (anterior and posterior palate) were examined. Alk-1 (a–
in the mesenchyme before and during the fusion, both anteriorly and posteriorly. T
that Alk-5 mRNAwas not detected in the posterior midline epithelial structures (k
as a positive control was detected in the palatal epithelium (q– t) as described (FiTgf-h3 ( / ) embryos, or in the wild-type MEE before
the contact of palatal shelves (Figs. 2a–f, m, n).
Smad2 overexpression via adenoviral transduction of
Tgf-h3 ( / ) palatal shelves induced focal mesenchymal
confluence of up to 100%, regardless to the anterior–
posterior position (Fig. 3a, n = 4, orange line). Moreover,
in regions showing an incomplete confluence, the midline
seam was very thin with only a single cell layer (Fig. 3b).
Transduction of wild-type palatal shelves with recombinant
adenoviruses expressing the inhibitory Smad7 resulted in
pronounced inhibition of palatal confluence (n = 4, P <
0.01; Fig. 3a, blue line).
In palatal organ cultures, the Alk inhibitor SB431542
(Inman et al., 2002), which has been shown to effectively
abrogate Smad2 phosphorylation, consistently prevented thee palatal shelves. (A–D) RT-PCR analysis of RNAs isolated from wild-type
), Alk-2 (B), and Alk-5 (C) mRNAs are expressed in palatal shelves, while
on palatal sections. Two time points (before and after the adhesion of palatal
d) and Alk-2 (e–h) mRNAs were present in the palatal epithelium as well as
he Alk-5 expression pattern (i – l) was similar to that of Alk-1 and 2, except
and l). Alk-7 mRNA (m–p) was undetectable in palatal tissues. Tgf-h3 used
tzpatrick et al., 1990; Pelton et al., 1990). Magnification 200.
M. Dudas et al. / Developmental Biology 266 (2004) 96–108102induction of anterior palatal confluence, while having no
effect on the posterior palate (Figs. 3c–e, n = 6).
These findings imply that the Tgf-h3 signal during
palatal fusion is mediated via Alk/Smad pathway, and that
activation of Smad2 is specific for the MES and plays a
critical role in establishing the mesenchymal confluence.
Endogenous expression of Tgf-b type I receptors in the
developing palate
Next, we analyzed the endogenous expression of the
candidate Tgf-h3 type I receptors (Alk-1, 2, 5, 7) in palatal
shelves. RT-PCR analysis demonstrated that Alk-1, Alk-2,
and Alk-5 mRNAs were all present in palatal tissues, whileFig. 5. Functional manipulation of Alks in the MES. (a–e) Expression of caAlk-
mesenchymal confluence when compared to Tgf-h3 ( / ) shelves transduced w
caAlk-5 and caAlk-2 (e) both lead to epithelial hypertrophy (arrows in a and e) w
magnification 200. (f) The anterior-to-posterior overview of the fusion efficiency
Alks. caAlks rescued the defect of Tgf-b3 ( / ) palatal shelves with different eff
in transduction timing influenced the fusion pattern by decreasing posterior and
overview of the fusion efficiency of wild-type palatal shelves expressing dominan
and 5 (n = 5). dnAlk-5 prevents fusion of wild-type palatal shelves more efficientl
on palatal fusion. The co-expression of caAlk-5 and caAlk-2 inhibits palatal fusiexpression of the nodal receptor, Alk-7 (Reissmann et al.,
2001), was not detected (Figs. 4A–D). Detailed analysis
using RNA ISH on sections revealed that Alk-1 and 2 are
expressed predominantly in the palatal mesenchyme and in
the oral or nasal palatal epithelium. Less intense expression
was seen in the MEE before contact of palatal shelves (Figs.
4a, c, e, g). Positive staining was detected also in the
disappearing midline epithelial seam during fusion (Figs.
4b, d, f, h). Alk-7 expression was not detected in palatal
tissues. Alk-5 mRNA was present in both epithelium and
mesenchyme of palatal shelves, except in the posterior
region, where we did not detect any signal in the MEE
before the fusion, nor in the MES during the fusion of
shelves (Figs. 4i–l).5 (c) and caAlk-2 (b) in the Tgf-h3 ( / ) palatal epithelium restores the
ith GFP (d). Misexpression of caAlk-1 (a) and simultaneous expression of
ith multiple epithelial globular islands (Fig. 6). Hematoxylin-eosin staining,
of Tgf-h3-deficient palatal shelves expressing constitutively active forms of
iciency in the order caAlk-1 < < caAlk-2 < caAlk-5 (n = 5, 4, 4). A change
increasing anterior fusion efficiency (caAlk-5 - II). (g) Anterior–posterior
t-negative (dn) Alk-2 (n = 5) and Alk-5 (n = 5), and co-expressing caAlk-2
y than dnAlk-2, while the control GFP viruses do not have detectable effect
on in wild-type specimens.
ental Biology 266 (2004) 96–108 103Adenoviral expression of constitutively active Alk mutants in
the Tgf-b3 (/) palatal epithelium
Tgf-h3 knockout palatal shelves were transduced using
adenoviruses expressing constitutively active forms of pu-
tative Tgf-h3 type I receptors detected in palatal tissues:
caAlk-5 (Alk-5TD), caAlk-2 (Alk-2QD), caAlk-1 (Alk-
1QD). While control GFP viruses did not cause any detect-
able effect (Fig. 5d), the mesenchymal confluence of palatal
shelves from Tgf-h3 ( / ) embryos was consistently
restored by caAlk-5 (Fig. 5c, n = 4). Interestingly, a similar
pattern of restoration was observed with caAlk-2 viruses,
although to a lesser degree (Figs. 5b, f; n = 4). While the
effect of caAlk-1 viruses on mesenchymal confluence was
negligible, these palates displayed marked epithelial hyper-
trophy, which was not seen in specimens transduced with
either caAlk-2 or caAlk-5 (Fig. 5a, n = 5). In summary, a
misexpression of constitutively active Alk receptors in Tgf-
h3 ( / ) palatal epithelium restores the mesenchymal
confluence with the following efficiency: caAlk-5 (46%) >
caAlk-2 (31%) caAlk-1 (7%). The confluence-enhancing
effects of caAlk-2 and 5 were statistically significant (n = 4,
P < 0.01).
M. Dudas et al. / DevelopmFig. 6. Simultaneous misexpression of caAlk-2 and caAlk-5 in the MES leads to in
caAlk-2 and caAlk-5 display increased cell proliferation in the MES 21 and 41
transduced with GFP (a). BrdU staining, magnification 200. (d) The histogram s
(Alk-2 + 5) and control (GFP) specimens (n = 3; error scale bars indicate S.D.).
display decreased apoptosis in the MES 21 and 41 h after transduction (e, f; arrows
GFP (d; arrows—positive signal). TUNEL assay, FITC label; 200. (h) The hist
transduced (Alk-2 + 5) and control (GFP) specimens (n = 3; error scale bars indiIn addition, we tested the effect of co-expression of
the two most potent fusion-inducing Alks, that is, caAlk-
2 together with caAlk-5, in the palatal midline epitheli-
um. Surprisingly, the combination of caAlk-2 + 5 did not
act synergistically to rescue the fusion defect in any part
of Tgf-h3 ( / ) palatal explants. Furthermore, this
combination significantly inhibited induction of mesen-
chymal confluence in wild-type explants (n = 5, P <
0.01; Fig. 5g). The MES in both genotypes contained
multiple globular epithelial structures, and the epithelium
displayed marked hypertrophy (Fig. 5e), resembling the
epithelium infected with caAlk-1. Hypertrophic regions
displayed a marked increase in cell proliferation when
compared to the GFP-transduced controls. Furthermore,
the number of cells undergoing apoptosis detected by
TUNEL assay was decreased in hypertrophic midline
seams (Fig. 6). These results imply that while both
Alk-5 and Alk-2 are endogenously expressed and acti-
vated in palatal epithelium, an imbalance in these two
signaling pathways (spatial, temporal, or stoichiometric)
can impair developmental programming of palatal fusion.
The fact that both cell proliferation and apoptosis were
affected provides further evidence that Tgf-h signalingcrease in cell proliferation and survival. (a–c) Samples co-transduced with
h after transduction (b, c—arrows) when compared with control samples
hows the number of BrdU-positive cells per cross-section in co-transduced
(e–g) Samples with simultaneous misexpression of caAlk-2 and caAlk-5
—MES without detectable signal) when compared with a control expressing
ogram shows the number of TUNEL-labeled cells per cross-section in co-
cate SD).
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the MEE.
Effect of transduction timing on the anterior–posterior
distribution of confluence
In standard organ cultures, the effect of caAlks on
induction of mesenchymal confluence was more prominent
in the posterior palate (Fig. 5f). We reasoned that this
phenomenon was because the anterior palate is develop-
mentally more advanced, and that our standard transduction
and culture system do not allow an efficient protein pro-
duction to occur before the fusion starts. Indeed, Tgf-h3
( / ) shelves transduced at E13.5 and placed in close
contact at E14 displayed efficient induction of mesenchymal
confluence also in the anterior palate (Fig. 5f, orange dotted
line).
Adenoviral expression of dominant-negative Alk mutants in
the wild-type palatal epithelium
The role of Alk-5 and Alk-2 in palatogenesis was
further studied using transduction of wild-type E14 palatal
shelves with recombinant adenoviruses expressing their
dominant-negative (KR) forms. dnAlk-5 prevented induc-
tion of palatal confluence by 75% (Fig. 5g). The effi-
ciency of dnAlk-2 was weaker, resulting in approximately
40% inhibition, while GFP control adenoviruses did not
influence the fusion process in wild-type shelves; inhib-
itory effects caused by dnAlk-2 and dnAlk-5 were statis-Fig. 7. Noncanonical Tgf-h pathways and p38 Mapk in palatogenesis. (a) Western b
After 24 h, treated cells display high protein production (detected with Alk-5
endogenous Alk-5. caAlk-5mL45 was not able to induce Smad2 phosphorylation
fusion efficiency in Tgf-h3 ( / ) palatal explants expressing caAlk-5mL45. In
mesenchymal confluence (n = 5). (c) The inhibitory effect of p38 Mapk inhibitor S
min after the addition of Tgf-h3. (d) Chemical inhibition of p38 Mapk by SB20358
in the anterior region (n = 5, red line).tically significant (n = 5, P < 0.01). Taken together with
the results presented in Fig. 5f, our findings show that
Alk-5 is the primary type I receptor mediating Tgf-h3
signaling in palatogenesis.
Smad-independent Tgf-b signaling pathways and palatal
fusion
We then generated a recombinant adenovirus expressing
caAlk5 mutated in the L45 loop (caAlk-5mL45), which has
a functional kinase domain, but is unable to properly
interact with Smad2 and to phosphorylate it (Yu et al.,
2002). In contrast to NMuMG cells transduced with caAlk-
5 viruses, cells transduced with caAlk-5mL45 did not show
any detectable Smad2 phosphorylation (Fig. 7a), whereas
p38 Mapk was phosphorylated similarly in cells infected
with caAlk-5 or caAlk-5mL45 (data not shown). Next, we
tested the effect of this viral preparation on palatal shelves
deficient in Tgf-h3. As shown in Fig. 7b, caAlk-5mL45
was not able to induce fusion of Tgf-h3 ( / ) palatal
shelves (n = 5).
The p38 Mapk inhibitor (SB203580) had an inhibitory
effect on fusion of the wild-type palate (Fig. 7d, n = 5).
Since the kinase inhibitors are known to have a broader
spectrum of action (Davies et al., 2000), we tested
whether the Tgf-h3-induced Smad2 phosphorylation is
affected by this inhibitor. In NMuMG cells, SB203580
caused only a modest, about 30% reduction in Smad2
phosphorylation at the concentration used for palatal
experiments (Fig. 7c).lot analysis of cells transduced with adenoviruses expressing caAlk-5mL45.
antibody, upper panel). 293A cells were used, since they do not express
in NMuMG cells (bottom panel). (b) The anterior-to-posterior overview of
contrast to fully functional caAlk-5, caAlk-5mL45 was not able to induce
B203580 on Tgf-h3-induced Smad2 phosphorylation in NMuMG cells 100
0 partially impairs fusion of wild-type palatal shelves in vitro, preferentially
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stream signaling is an absolute requirement for palatal
fusion mediated by Alk-5 receptor. While the activity of
p38 Mapk may be necessary for successful palatogenesis,
the activation of the noncanonical (Smad-independent) Tgf-
h signaling pathway alone is not sufficient to induce fusion
of palatal shelves deficient in Tgf-h3.Discussion
Tgf-b type I receptors (Alks) in palatal fusion
In this study, we provide evidence for the first time that
Tgf-h3 signaling in the anterior palatal MEE is predomi-
nantly mediated by Alk-5. This evidence is based on (i) the
observation that Alk-5 is expressed exclusively in the
anterior palatal epithelium, (ii) the demonstration that the
chemical Alk-5 inhibitor, as well as dnAlk-5, prevented the
induction of mesenchymal confluence only in the anterior
palate, and (iii) the demonstration that caAlk-5 could
rescue the fusion defect of the Tgf-h3 ( / ) palatal
explants.
Furthermore, constitutively active Alk-2 could also
rescue the failed induction of mesenchymal confluence
of the Tgf-h3 ( / ) shelves, albeit less efficiently than
caAlk-5. This is remarkable, since in concordance with
published studies (Piek et al., 1999b), our experiments on
NMuMG cells demonstrated that caAlk-2 viruses were not
able to induce typical Tgf-h responses, such as EMT
(data not shown). Moreover, Alk-5 and Alk-2 are current-
ly believed to mediate very different signaling events.
While Alk-5 signaling is primarily mediated by R-Smads
2 and 3, the Alk-2 signal is mediated by typical Bmp R-
Smads 1 and 5. Therefore, Alk-2 is generally considered
to mediate Bmp, rather than Tgf-h signals (Macias-Silva
et al., 1998; Massague, 1998). Surprisingly, Alk-1, which
is closely related to Alk-2, was not able to induce
noticeable palatal confluence, but instead caused pro-
nounced midline epithelial hypertrophy. This finding sug-
gests that signaling specificity of these two closely related
receptors is not defined only by differences in ligand
binding, but also relatively subtle differences in intracel-
lular domains could result in notable divergence in
signaling specificity in vivo.
Simultaneous activation of Alk-5 and Alk-2 signaling
pathways
It has been recently shown that Alk-1 mediates specific
Tgf-h responses together with Alk-5 in endothelial cells
(Goumans et al., 2002; Oh et al., 2000). Therefore, we
tested whether Alk-2 (highly homologous to Alk-1) would
act similarly in concert with Alk-5 in MEE cells. Co-
expression of caAlk-2 and 5 caused dramatic hypertrophy
of the midline epithelium both in wild-type and in Tgf-h3knockout tissues, as well as efficient inhibition of fusion in
wild-type palatal explants. Using an epithelial cell culture
model, we subsequently showed that co-expression of
caAlk-2 and caAlk-5 reduced the level of Smad2 phosphor-
ylation and impaired epithelial–mesenchymal transdifferen-
tiation (data not shown). Together with the increased cell
proliferation detected in hypertrophic regions of the palatal
explants co-expressing caAlk-2 and 5, these results demon-
strate that Tgf-h signaling plays a significant role in growth
regulation of the midline epithelium. This is in agreement
with a recent report suggesting that one function of Tgf-h3
signaling in the MEE is to downregulate MEE cell prolif-
eration (Cui et al., 2003).
Smad-dependent signaling and anterior–posterior
differences in palatal fusion
Canonical Tgf-h signaling involves activation of Smad2
and/or 3. Mice deficient in Smad2 are unable to form the
embryonic mesoderm and die during or immediately after
gastrulation (Nomura and Li, 1998), preventing the use of
these mice in palatal studies (Heyer et al., 1999; Waldrip et
al., 1998; Weinstein et al., 1998). In contrast, Smad3
knockout mice are born alive and lack obvious develop-
mental defects (Datto et al., 1999; Yang et al., 1999; Zhu et
al., 1998), suggesting that the role of Smad3 in palato-
genesis, if any, is redundant and that it can be functionally
compensated by Smad2.
Our finding that the MEE deficient in Tgf-h3 failed to
display Smad2 phosphorylation, and nuclear localization
implies that Smad2 activation in the MEE is specifically
induced by Tgf-h3. It has been previously shown that
overexpression of wild-type R-Smads overwhelms rate-
limiting levels of Sara adaptor protein, leading to oligomer-
ization without receptor-induced phosphorylation and to
constitutive activation of the pathway (Moustakas and
Heldin, 2002; Qin et al., 2002). Therefore, we overex-
pressed wild-type Smad2 in the MEE to provide additional
evidence that Smad2 functions as a necessary signal trans-
ducer in TGF-h3-induced palatogenesis.
Although it has been described that palatal fusion pro-
gresses along an anterior–posterior gradient in vivo (Taya et
al., 1999), anteroposterior functional differences in palatal
shelves are currently not well understood. In the present
study, we show that Alk-5 is expressed exclusively in the
MEE of the anterior region. This pattern is very similar to that
reported for many other signaling molecules such as Bmp-2
and Sonic hedgehog (Zhang et al., 2002). Also, it was
recently shown that MEE cells in the posterior palate undergo
apoptosis before the contact of apposing shelves, while
apoptosis in the anterior palate is contact dependent (Cuervo
et al., 2002). Interestingly, contact-dependent apoptosis co-
localizes with Alk-5 expression detected in this study. In
concordance with the lack of Alk-5 expression in the poste-
rior palatal epithelium, the Alk-5 inhibitor SB431542 was
unable to inhibit posterior epithelial fusion. Thus, the exact
M. Dudas et al. / Developmental Biology 266 (2004) 96–108106mechanism of Smad2 phosphorylation in the posterior palatal
epithelium remains unclear and requires further investigation.
Smad-independent signaling in palatal fusion
Tgf-h signals can also be mediated via Smad-indepen-
dent pathways, involving signaling proteins such as p38
Mapk, Rho-kinase, and PI-3 kinase (Bakin et al., 2000;
Bhowmick et al., 2001a; Bhowmick et al., 2001b; Yu et al.,
2002). At least some of these signaling mechanisms could
play a role in palatogenesis (Kaartinen et al., 2002; Kang
and Svoboda, 2002). Moreover, Tgf-h-mediated activation
of p38 Mapk, which is independent of receptor-mediated
Smad activation, was shown to be required for Tgf-h-
induced EMT and apoptosis, but not for growth arrest (Yu
et al., 2002). It is likely that Smad-dependent and Smad-
independent pathways crosstalk strongly, or may even be
mutually dependent on each other (Itoh et al., 2003; Take-
kawa et al., 2002).
As shown by Yu et al., Alk-5 mutated in the L45 loop
(caAlk-5mL45) displays a strong kinase activity similar to
that of caAlk-5, but is unable to bind and phosphorylate
Smad2. While being incapable of eliciting Smad-dependent
downstream responses, caAlk-5mL45 was shown to be able
to activate p38 Mapk (Yu et al., 2002). This allows the
discrimination between canonical (Smad-dependent) and
noncanonical (Smad-independent) Tgf-h downstream
responses. Here we show that caAlk-5mL45 was not able
to induce mesenchymal confluence in Tgf-h3 ( / )
palatal explants, while at the same developmental stage,
caAlk-5 had a strong positive effect. This demonstrates that
Smad2-dependent signaling via Alk-5 receptor is absolutely
required for palatal fusion, while the activation of non-
canonical pathways alone (associated with p38 Mapk acti-
vation) is not sufficient.
The p38 Mapk inhibitor SB203580 belongs to a group of
specific inhibitors, although it has also been shown to
inhibit several other kinases, including Alk-5, albeit at much
higher concentrations (IC50 for p38 Mapk is more than 20
times lower than for Alk-5) (Davies et al., 2000; Yakymo-
vych et al., 2002). In our experiments, the effect of p38
Mapk inhibitor SB203580 on palatal fusion strongly resem-
bled the effect of the Alk-5 inhibitor SB431542. At doses
used in palatal experiments, we detected only a slight
inhibition (around 30%) of Smad2 phosphorylation by
SB203580 in NMuMG cells treated with Tgf-h3, in agree-
ment with the results of Yu et al. (2002). However, the
biological response in palatal tissue may differ from that
seen in cell cultures; the more pronounced effect in anterior
parts of explants may be caused by the interference with
Smad2 phosphorylation. The physiological anterior–poste-
rior direction of palatal fusion might also play a role, as
discussed above. The exact mechanism of p38 Mapk
activation by Alk-5 is currently unknown. Elucidation of
this process may define the nature of Smad-independent
Tgf-h signaling during palatogenesis.Conclusions
Based on the expression pattern, and the pronounced
effect of Alk-5 functional manipulations on palatal fusion in
comparison with other examined Alk receptors, we con-
clude that Alk-5 is the dominant receptor in Tgf-h3-medi-
ated fusion of anterior parts of palatal shelves. Furthermore,
the evidence that Smad2 phosphorylation is indispensable
for Tgf-h3-mediated palatal responses provides strong sup-
port for this. However, certain anterior–posterior functional
differences in palatal shelves and the inhibitory effect on
palatal fusion after co-expression of caAlk-5 with caAlk-2
suggest that the signaling logic is more complex and the
involvement of other signaling pathways in palatal fusion
awaits clarification.Acknowledgments
We thank Dr. Wai-Yee Li for critical comments on the
manuscript, and Stijn De Langhe for generation of the Alk-2
ISH probe. This work was supported by the CHLA RCDF
Award (to M.D.), the Robert E. Schneider Foundation, the
Cleft Palate Foundation, and the PHS NIH grant DE13085
(to V.K.).References
Bakin, A.V., Tomlinson, A.K., Bhowmick, N.A., Moses, H.L., Arteaga,
C.L., 2000. Phosphatidylinositol 3-kinase function is required for trans-
forming growth factor beta-mediated epithelial to mesenchymal transi-
tion and cell migration. J. Biol. Chem. 275, 36803–36810.
Bhowmick, N.A., Ghiassi, M., Bakin, A., Aakre, M., Lundquist, C.A.,
Engel, M.E., Arteaga, C.L., Moses, H.L., 2001a. Transforming growth
factor-beta1 mediates epithelial to mesenchymal transdifferentiation
through a RhoA-dependent mechanism. Mol. Biol. Cell 12, 27–36.
Bhowmick, N.A., Zent, R., Ghiassi, M., McDonnell, M., Moses, H.L.,
2001b. Integrin beta 1 signaling is necessary for transforming growth
factor-beta activation of p38MAPK and epithelial plasticity. J. Biol.
Chem. 276, 46707–46713.
Blavier, L., Lazaryev, A., Groffen, J., Heisterkamp, N., DeClerck, Y.A.,
Kaartinen, V., 2001. TGF-beta3-induced palatogenesis requires matrix
metalloproteinases. Mol. Biol. Cell 12, 1457–1466.
Callahan, J.F., Burgess, J.L., Fornwald, J.A., Gaster, L.M., Harling, J.D.,
Harrington, F.P., Heer, J., Kwon, C., Lehr, R., Mathur, A., Olson, B.A.,
Weinstock, J., Laping, N.J., 2002. Identification of novel inhibitors of
the transforming growth factor beta1 (TGF-beta1) type 1 receptor
(ALK5). J. Med. Chem. 45, 999–1001.
Cuervo, R., Valencia, C., Chandraratna, R.A., Covarrubias, L., 2002. Pro-
grammed cell death is required for palate shelf fusion and is regulated
by retinoic acid. Dev. Biol. 245, 145–156.
Cui, X.M., Chai, Y., Chen, J., Yamamoto, T., Ito, Y., Bringas, P., Shuler, C.F.,
2003. TGF-beta3-dependent SMAD2 phosphorylation and inhibition of
MEE proliferation during palatal fusion. Dev. Dyn. 227, 387–394.
Datto, M.B., Frederick, J.P., Pan, L., Borton, A.J., Zhuang, Y., Wang, X.F.,
1999. Targeted disruption of Smad3 reveals an essential role in trans-
forming growth factor beta-mediated signal transduction. Mol. Cell.
Biol. 19, 2495–2504.
Davies, S.P., Reddy, H., Caivano, M., Cohen, P., 2000. Specificity and
mechanism of action of some commonly used protein kinase inhibitors.
Biochem. J. 351, 95–105.
M. Dudas et al. / Developmental Biology 266 (2004) 96–108 107Derynck, R., Feng, 1997. TGF-beta receptor signaling. Biochim. Biophys.
Acta 1333, F105–F150.
Feng, X.H., Derynck, 1997. A kinase subdomain of transforming growth
factor-beta (TGF-beta) type I receptor determines the TGF-beta intra-
cellular signaling specificity. EMBO J. 16, 3912–3923.
Ferguson, M.W., 1988. Palate development. Development 103, 41–60
(Suppl.) .
Fitzpatrick, D.R., Denhez, F., Kondaiah, P., Akhurst, R.J., 1990. Differ-
ential expression of TGF beta isoforms in murine palatogenesis. Devel-
opment 109, 585–595.
Goumans, M.J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., Sideras, P., ten
Dijke, P., 2002. Balancing the activation state of the endothelium via
two distinct TGF-beta type I receptors. EMBO J. 21, 1743–1753.
Gu, Z., Reynolds, E.M., Song, J., Lei, H., Feijen, A., Yu, L., He, W.,
MacLaughlin, D.T., van den Eijnden-van Raaij, J., Donahoe, P.K., Li,
E., 1999. The type I serine/threonine kinase receptor ActRIA (ALK2) is
required for gastrulation of the mouse embryo. Development 126,
2551–2561.
Harlow, E., Lane, 1988. Antibodies. A Laboratory Manual. CSH Press,
New York.
Heyer, J., Escalante-Alcalde, D., Lia, M., Boettinger, E., Edelmann, W.,
Stewart, C.L., Kucherlapati, R., 1999. Postgastrulation Smad2-deficient
embryos show defects in embryo turning and anterior morphogenesis.
Proc. Natl. Acad. Sci. U. S. A. 96, 12595–12600.
Inman, G.J., Nicolas, F.J., Callahan, J.F., Harling, J.D., Gaster, L.M., Reith,
A.D., Laping, N.J., Hill, C.S., 2002. SB-431542 is a potent and specific
inhibitor of transforming growth factor-beta superfamily type I activin
receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol.
Pharmacol. 62, 65–74.
Itoh, S., Thorikay, M., Kowanetz, M., Moustakas, A., Itoh, F., Heldin,
C.H., ten Dijke, P., 2003. Elucidation of Smad requirement in trans-
forming growth factor-beta type I receptor-induced responses. J. Biol.
Chem. 278, 3751–3761.
Kaartinen, V., Voncken, J.W., Shuler, C., Warburton, D., Bu, D., Heist-
erkamp, N., Groffen, J., 1995. Abnormal lung development and cleft
palate in mice lacking TGF-beta 3 indicates defects of epithelial–mes-
enchymal interaction. Nat. Genet. 11, 415–421.
Kaartinen, V., Cui, X.M., Heisterkamp, N., Groffen, J., Shuler, C.F., 1997.
Transforming growth factor-beta3 regulates transdifferentiation of me-
dial edge epithelium during palatal fusion and associated degradation of
the basement membrane. Dev. Dyn. 209, 255–260.
Kaartinen, V., Haataja, L., Nagy, A., Heisterkamp, N., Groffen, J., 2002.
TGFbeta3-induced activation of RhoA/Rho-kinase pathway is neces-
sary but not sufficient for epithelio-mesenchymal transdifferentiation:
implications for palatogenesis. Int. J. Mol. Med. 9, 563–570.
Kang, P., Svoboda, 2002. PI-3 kinase activity is required for epithelial–
mesenchymal transformation during palate fusion. Dev. Dyn. 225,
316–321.
Kurisaki, K., Kurisaki, A., Valcourt, U., Terentiev, A.A., Pardali, K., ten
Dijke, P., Heldin, C.H., Ericsson, J., Moustakas, A., 2003. Nuclear
factor YY1 inhibits transforming growth factor beta- and bone mor-
phogenetic protein-induced cell differentiation. Mol. Cell. Biol. 23,
4494–4510.
Lai, Y.T., Beason, K.B., Brames, G.P., Desgrosellier, J.S., Cleggett, M.C.,
Shaw, M.V., Brown, C.B., Barnett, J.V., 2000. Activin receptor-like
kinase 2 can mediate atrioventricular cushion transformation. Dev. Biol.
222, 1–11.
Larsson, J., Goumans, M.J., Sjostrand, L.J., van Rooijen, M.A., Ward, D.,
Leveen, P., Xu, X., ten Dijke, P., Mummery, C.L., Karlsson, S., 2001.
Abnormal angiogenesis but intact hematopoietic potential in TGF-beta
type I receptor-deficient mice. EMBO J. 20, 1663–1673.
Lidral, A.C., Romitti, P.A., Basart, A.M., Doetschman, T., Leysens, N.J.,
Daack-Hirsch, S., Semina, E.V., Johnson, L.R., Machida, J., Burds, A.,
Parnell, T.J., Rubenstein, J.L., Murray, J.C., 1998. Association of
MSX1 and TGFB3 with nonsyndromic clefting in humans. Am. J.
Hum. Genet. 63, 557–568.
Macias-Silva, M., Hoodless, P.A., Tang, S.J., Buchwald, M., Wrana, J.L.,1998. Specific activation of Smad1 signaling pathways by the BMP7
type I receptor, ALK2. J. Biol. Chem. 273, 25628–25636.
Martinez-Alvarez, C., Bonelli, R., Tudela, C., Gato, A., Mena, J., O’Kane,
S., Ferguson, M.W., 2000. Bulging medial edge epithelial cells and
palatal fusion. Int. J. Dev. Biol. 44, 331–335.
Massague, J., 1998. TGF-beta signal transduction. Annu. Rev. Biochem.
67, 753–791.
Massague, J., 2000. How cells read TGF-beta signals. Nat. Rev., Mol. Cell
Biol. 1, 169–178.
Massague, J., Chen, 2000. Controlling TGF-beta signaling. Genes Dev. 14,
627–644.
Miettinen, P.J., Ebner, R., Lopez, A.R., Derynck, R., 1994. TGF-beta in-
duced transdifferentiation of mammary epithelial cells to mesenchymal
cells: involvement of type I receptors. J. Cell Biol. 127, 2021–2036.
Mishina, Y., Crombie, R., Bradley, A., Behringer, R.R., 1999. Multiple
roles for activin-like kinase-2 signaling during mouse embryogenesis.
Dev. Biol. 213, 314–326.
Moorman, A.F., Houweling, A.C., de Boer, P.A., Christoffels, V.M., 2001.
Sensitive nonradioactive detection of mRNA in tissue sections: novel
application of the whole-mount in situ hybridization protocol. J. Histo-
chem. Cytochem. 49, 1–8.
Moustakas, A., Heldin, 2002. From mono- to oligo-Smads: the heart of the
matter in TGF-beta signal transduction. Genes Dev. 16, 1867–1871.
Nakao, A., Imamura, T., Souchelnytskyi, S., Kawabata, M., Ishisaki, A.,
Oeda, E., Tamaki, K., Hanai, J., Heldin, C.H., Miyazono, K., ten Dijke,
P., 1997. TGF-beta receptor-mediated signalling through Smad2, Smad3
and Smad4. EMBO J. 16, 5353–5362.
Nomura, M., Li, 1998. Smad2 role in mesoderm formation, left – right
patterning and craniofacial development. Nature 393, 786–790.
Oh, S.P., Seki, T., Goss, K.A., Imamura, T., Yi, Y., Donahoe, P.K., Li, L.,
Miyazono, K., ten Dijke, P., Kim, S., Li, E., 2000. Activin receptor-
like kinase 1 modulates transforming growth factor-beta 1 signaling in
the regulation of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 97,
2626–2631.
Pelton, R.W., Dickinson, M.E., Moses, H.L., Hogan, B.L., 1990. In situ
hybridization analysis of TGF beta 3 RNA expression during mouse
development: comparative studies with TGF beta 1 and beta 2. Devel-
opment 110, 609–620.
Piek, E., Heldin, C.H., ten Dijke, P., 1999a. Specificity, diversity, and reg-
ulation in TGF-beta superfamily signaling. FASEB J. 13, 2105–2124.
Piek, E., Moustakas, A., Kurisaki, A., Heldin, C.H., ten Dijke, P., 1999b.
TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial
to mesenchymal transdifferentiation in NMuMG breast epithelial cells.
J. Cell Sci. 112 (Pt. 24), 4557–4568.
Proetzel, G., Pawlowski, S.A., Wiles, M.V., Yin, M., Boivin, G.P., Howles,
P.N., Ding, J., Ferguson, M.W., Doetschman, T., 1995. Transforming
growth factor-beta 3 is required for secondary palate fusion. Nat. Genet.
11, 409–414.
Qin, B.Y., Lam, S.S., Correia, J.J., Lin, K., 2002. Smad3 allostery links
TGF-beta receptor kinase activation to transcriptional control. Genes
Dev. 16, 1950–1963.
Reissmann, E., Jornvall, H., Blokzijl, A., Andersson, O., Chang, C., Min-
chiotti, G., Persico, M.G., Ibanez, C.F., Brivanlou, A.H., 2001. The
orphan receptor ALK7 and the activin receptor ALK4 mediate signaling
by nodal proteins during vertebrate development. Genes Dev. 15,
2010–2022.
Sun, D., Vanderburg, C.R., Odierna, G.S., Hay, E.D., 1998. TGFbeta3
promotes transformation of chicken palate medial edge epithelium to
mesenchyme in vitro. Development 125, 95–105.
Takekawa, M., Tatebayashi, K., Itoh, F., Adachi, M., Imai, K., Saito, H.,
2002. Smad-dependent GADD45beta expression mediates delayed ac-
tivation of p38 MAP kinase by TGF-beta. EMBO J. 21, 6473–6482.
Taya, Y., O’Kane, S., Ferguson, M.W., 1999. Pathogenesis of cleft palate in
TGF-beta3 knockout mice. Development 126, 3869–3879.
Waldrip, W.R., Bikoff, E.K., Hoodless, P.A., Wrana, J.L., Robertson, E.J.,
1998. Smad2 signaling in extraembryonic tissues determines anterior–
posterior polarity of the early mouse embryo. Cell 92, 797–808.
M. Dudas et al. / Developmental Biology 266 (2004) 96–108108Weinstein, M., Yang, X., Li, C., Xu, X., Gotay, J., Deng, C.X., 1998.
Failure of egg cylinder elongation and mesoderm induction in mouse
embryos lacking the tumor suppressor smad2. Proc. Natl. Acad. Sci.
U. S. A. 95, 9378–9383.
Yakymovych, I., Engstrom, U., Grimsby, S., Heldin, C.H., Souchelnytskyi,
S., 2002. Inhibition of transforming growth factor-beta signaling by low
molecular weight compounds interfering with ATP- or substrate-bind-
ing sites of the TGF beta type I receptor kinase. Biochemistry 41,
11000–11007.
Yang, X., Letterio, J.J., Lechleider, R.J., Chen, L., Hayman, R., Gu, H.,
Roberts, A.B., Deng, C., 1999. Targeted disruption of SMAD3 resultsin impaired mucosal immunity and diminished T cell responsiveness to
TGF-beta. EMBO J. 18, 1280–1291.
Yu, L., Hebert, M.C., Zhang, Y.E., 2002. TGF-beta receptor-activated p38
MAP kinase mediates Smad-independent TGF-beta responses. EMBO
J. 21, 3749–3759.
Zhang, Z., Song, Y., Zhao, X., Zhang, X., Fermin, C., Chen, Y., 2002.
Rescue of cleft palate in Msx1-deficient mice by transgenic Bmp4
reveals a network of BMP and Shh signaling in the regulation of mam-
malian palatogenesis. Development 129, 4135–4146.
Zhu, Y., Richardson, J.A., Parada, L.F., Graff, J.M., 1998. Smad3 mutant
mice develop metastatic colorectal cancer. Cell 94, 703–714.
